YGR210C Antibody

What is YGR210C and why is it significant for research?

YGR210C is a gene in Saccharomyces cerevisiae (budding yeast) identified in the S288c strain. This gene is significant in yeast biology research as it appears in various genomic studies. Researchers typically develop antibodies against the protein product of this gene to study its function, localization, and interactions within yeast cells. The protein's significance comes from its potential roles in fundamental cellular processes that may be conserved across eukaryotes, making it valuable for comparative studies between yeast and higher organisms including humans .

What types of antibodies are commonly used for detecting YGR210C protein?

Researchers typically use several types of antibodies for YGR210C protein detection:

• Monoclonal antibodies: Provide high specificity but recognize only a single epitope

• Polyclonal antibodies: Recognize multiple epitopes but may have more background

• Tagged-protein antibodies: Often used when studying the tagged version of YGR210C

For optimal results, researchers frequently employ affinity-purified antibodies that target specific regions of the YGR210C protein. The selection depends on the experimental approach, with western blotting typically using denaturation-resistant epitope-targeting antibodies, while immunoprecipitation and ChIP assays benefit from antibodies that recognize native protein conformations .

How should I validate a new YGR210C antibody before using it in critical experiments?

Validation of a YGR210C antibody should follow a systematic approach:

• Specificity testing:

  • Compare signals between wild-type and YGR210C knockout strains

  • Test antibody against recombinant YGR210C protein

  • Perform peptide competition assays

• Application-specific validation:

  • For western blotting: Verify the band appears at the expected molecular weight (~predicted kDa)

  • For immunoprecipitation: Confirm enrichment of the target protein by mass spectrometry

  • For immunofluorescence: Compare localization patterns with published data or GFP-tagged versions

• Cross-reactivity assessment:

  • Test against closely related proteins to ensure specificity

  • Evaluate potential off-target binding

Ideally, validation should use multiple techniques to confirm antibody performance across different experimental conditions .

What are the best experimental controls when using YGR210C antibodies?

Proper controls are essential for reliable YGR210C antibody experiments:

• Negative controls:

  • YGR210C deletion strain (YGR210C-Δ)

  • Isotype control antibodies (same antibody class, irrelevant specificity)

  • Secondary antibody-only controls to assess non-specific binding

• Positive controls:

  • Strains overexpressing YGR210C

  • Recombinant YGR210C protein at known concentrations

  • GFP-tagged YGR210C with parallel anti-GFP detection

• Technical controls:

  • Loading controls for western blots (e.g., actin, GAPDH)

  • Spike-in controls for quantitative experiments

• Validation controls:

  • Peptide competition assays to confirm specificity

  • Multiple antibodies targeting different epitopes of YGR210C

These controls help distinguish specific signals from background and validate experimental findings .

How do I determine the optimal antibody concentration for my specific application?

Determining optimal antibody concentration requires systematic titration:

• Western blotting:

  • Start with a broad range (1:100 to 1:10,000 dilution)

  • Perform serial dilutions to identify the concentration with optimal signal-to-noise ratio

  • Consider using a dot blot approach for initial screening

• Immunoprecipitation:

  • Test antibody amounts ranging from 1-10 μg per sample

  • Assess protein recovery using western blot of input, unbound, and eluted fractions

  • Optimize antibody-to-bead ratio (typically 2-5 μg antibody per 20-50 μl of beads)

• Immunofluorescence:

  • Begin with manufacturer's recommendation or 1:200 dilution

  • Create a dilution series (e.g., 1:100, 1:200, 1:500, 1:1000)

  • Select concentration that maximizes specific signal while minimizing background

• ChIP assays:

  • Test 1-10 μg per immunoprecipitation reaction

  • Validate enrichment at known target sites using qPCR before proceeding to sequencing

Document all optimization steps methodically to ensure reproducibility across experiments .

What is the most effective protocol for immunoprecipitation of YGR210C protein?

Effective immunoprecipitation of YGR210C requires careful attention to lysis conditions and protein preservation:

Optimized Protocol:

• Cell preparation and lysis:

  • Harvest 50-100 ml of yeast culture at OD600 = 0.8-1.0

  • Wash cells in cold PBS with protease inhibitors

  • Lyse cells in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and protease inhibitor cocktail

  • Disrupt cells with glass beads (5 cycles of 1 min vortexing with 1 min cooling on ice)

• Pre-clearing:

  • Centrifuge lysate at 14,000 × g for 15 min at 4°C

  • Incubate cleared supernatant with Protein A/G beads for 1 hour at 4°C

  • Remove beads by centrifugation

• Immunoprecipitation:

  • Add 2-5 μg of anti-YGR210C antibody to pre-cleared lysate

  • Incubate overnight at 4°C with gentle rotation

  • Add 30-50 μl of pre-washed Protein A/G beads

  • Incubate for 2-3 hours at 4°C

• Washing and elution:

  • Wash beads 4-5 times with lysis buffer

  • Perform final wash with PBS

  • Elute protein by boiling in SDS sample buffer or use gentle elution with peptide competition

This protocol has been optimized based on approaches used for other yeast proteins and can be adjusted based on specific experimental needs .

How can I optimize ChIP-seq experiments using YGR210C antibodies?

Optimizing ChIP-seq with YGR210C antibodies requires several critical considerations:

• Crosslinking optimization:

  • Test different formaldehyde concentrations (0.75-1.5%)

  • Optimize crosslinking time (10-20 minutes)

  • Consider dual crosslinking with DSG for improved protein-protein capture

• Sonication parameters:

  • Adjust sonication conditions to generate 200-500 bp fragments

  • Verify fragmentation efficiency by agarose gel electrophoresis

  • Optimize cycles and amplitude based on your sonicator model

• IP conditions:

  • Determine optimal antibody amount (typically 2-5 μg per IP)

  • Test different antibody incubation times (overnight to 48 hours)

  • Consider using a combination of antibodies targeting different epitopes

• Controls and validation:

  • Include input control, IgG control, and technical replicates

  • Validate enrichment at known targets by qPCR before sequencing

  • Consider spike-in controls for quantitative analysis

• Library preparation considerations:

  • Use appropriate library preparation method for low-input samples

  • Optimize PCR cycles to minimize duplicates while maintaining complexity

  • Consider unique molecular identifiers (UMIs) for quantitative applications

For peak calling analysis, use appropriate algorithms that can detect both narrow and broad peaks, as the binding pattern of YGR210C may vary depending on its functional context .

What are the best practices for using YGR210C antibodies in immunofluorescence microscopy?

For optimal immunofluorescence with YGR210C antibodies:

• Fixation optimization:

  • Test both paraformaldehyde (3-4%) and methanol fixation

  • For yeast cells, consider spheroplasting before fixation

  • Optimize fixation time (10-30 minutes) to balance epitope preservation and cellular structure

• Permeabilization:

  • Use 0.1% saponin or 0.1-0.5% Triton X-100

  • Test different permeabilization times (5-15 minutes)

  • For yeast, zymolyase treatment may be necessary for cell wall digestion

• Blocking:

  • Block with 5% goat serum and 1% BSA in PBS

  • Extend blocking time to 60 minutes for reduced background

  • Consider adding 0.1% saponin to blocking buffer for maintained permeabilization

• Antibody incubation:

  • Test different antibody dilutions (1:100 to 1:1000)

  • Incubate primary antibody overnight at 4°C

  • Use fluorophore-conjugated secondary antibodies appropriate for your microscope filters

• Controls and co-staining:

  • Include YGR210C knockout controls

  • Co-stain with organelle markers to determine precise localization

  • Consider counterstaing with DAPI for nuclear visualization

• Mounting and imaging:

  • Use anti-fade mounting medium

  • Acquire z-stacks for complete cellular distribution

  • Consider deconvolution for improved resolution

This approach is based on standard immunofluorescence protocols adapted specifically for yeast cells .

How do I distinguish between specific and non-specific signals when using YGR210C antibodies?

Distinguishing specific from non-specific signals requires a systematic approach:

• Control-based verification:

  • Compare signals between wild-type and YGR210C knockout samples

  • Evaluate signals in the presence of blocking peptides

  • Assess background with secondary antibody-only controls

• Signal characteristics analysis:

  • Specific signals should appear at the predicted molecular weight in western blots

  • Specific localization patterns should be consistent with known biology

  • Signal intensity should correlate with protein expression levels in different conditions

• Multiple detection methods:

  • Confirm findings using different antibodies targeting different epitopes

  • Validate with orthogonal techniques (e.g., mass spectrometry)

  • Compare with GFP-tagged protein detection if available

• Statistical approaches:

  • For quantitative applications, determine signal-to-noise ratios

  • Apply appropriate statistical tests to evaluate significance

  • Consider replicate variability and biological significance thresholds

When uncertain, peptide competition assays remain the gold standard for confirming specificity, where pre-incubation of the antibody with its target peptide should abolish specific signals .

How should I normalize and quantify western blot data when analyzing YGR210C protein levels?

Proper normalization and quantification of YGR210C western blot data requires:

• Loading control selection:

  • Use housekeeping proteins appropriate for yeast (e.g., actin, GAPDH, tubulin)

  • Consider total protein staining methods (Ponceau S, SYPRO Ruby, Stain-Free technology)

  • Validate that loading controls are not affected by your experimental conditions

• Image acquisition:

  • Capture images within the linear dynamic range of your detection system

  • Use a digital imaging system rather than film for quantitative analysis

  • Avoid saturated pixels that will underestimate differences

• Quantification methodology:

  • Use densitometry software (ImageJ, Image Lab, etc.)

  • Define regions of interest consistently across all lanes

  • Subtract background using appropriate methods (rolling ball, adjacent area)

• Normalization approaches:

  • Primary method: Normalize target band intensity to loading control

  • For multiple blots: Include a common reference sample on each blot

  • Consider double normalization (to loading control and reference sample)

• Statistical analysis:

  • Perform experiments in biological triplicates at minimum

  • Apply appropriate statistical tests (t-test, ANOVA)

  • Report both normalized values and statistical significance

This approach ensures that observed changes in YGR210C protein levels are biologically meaningful rather than technical artifacts .

What are the common pitfalls in interpreting ChIP-seq data for YGR210C and how can I avoid them?

When interpreting YGR210C ChIP-seq data, be aware of these common pitfalls:

• Peak calling challenges:

  • Pitfall: Using inappropriate algorithms for the binding pattern

  • Solution: Test multiple peak callers (MACS2, HOMER, etc.) and validate with visual inspection

• Control normalization issues:

  • Pitfall: Inadequate normalization to input or IgG controls

  • Solution: Use both input and IgG controls; normalize using appropriate methods (RPKM, spike-in)

• False positives in repetitive regions:

  • Pitfall: Calling peaks in low mappability regions

  • Solution: Filter out regions with mapping quality issues; use uniquely mapped reads only

• Batch effects between samples:

  • Pitfall: Comparing samples processed separately

  • Solution: Process experimental and control samples together; use batch correction methods

• Biological relevance determination:

  • Pitfall: Focusing only on statistical significance without biological context

  • Solution: Integrate with gene expression data, other ChIP datasets, and relevant biological information

• Antibody specificity issues:

  • Pitfall: Interpreting peaks without validating antibody specificity

  • Solution: Validate using multiple antibodies; confirm key targets with ChIP-qPCR

• Motif analysis challenges:

  • Pitfall: Over-interpretation of enriched motifs

  • Solution: Use appropriate background models; validate motifs experimentally

To enhance interpretation, integrate ChIP-seq data with other genomic datasets (RNA-seq, ATAC-seq) for a comprehensive understanding of YGR210C function .

Why might I be getting weak or no signal in western blots using YGR210C antibodies?

Weak or absent western blot signals can result from several issues:

• Protein extraction problems:

  • Issue: Insufficient protein extraction from yeast cells

  • Solution: Optimize lysis method (bead beating, enzymatic digestion); include protease inhibitors

• Protein degradation:

  • Issue: YGR210C protein degraded during sample preparation

  • Solution: Keep samples cold; use fresh protease inhibitors; reduce processing time

• Transfer inefficiency:

  • Issue: Poor transfer of proteins to membrane

  • Solution: Optimize transfer conditions (time, voltage, buffer composition); verify transfer with reversible stain

• Antibody issues:

  • Issue: Antibody degradation or denaturation

  • Solution: Aliquot antibodies; avoid freeze-thaw cycles; store according to manufacturer's instructions

• Epitope accessibility:

  • Issue: Epitope masked by sample preparation method

  • Solution: Try different lysis buffers; reduce SDS concentration; test native vs. denaturing conditions

• Low protein expression:

  • Issue: YGR210C expressed at low levels

  • Solution: Increase sample loading; use more sensitive detection methods (ECL Advance, fluorescent detection)

• Detection system problems:

  • Issue: Inefficient secondary antibody binding or detection

  • Solution: Optimize secondary antibody dilution; extend exposure time; use fresh detection reagents

If problems persist, consider testing the antibody on recombinant YGR210C protein as a positive control to confirm functionality .

How can I reduce background noise in immunofluorescence experiments with YGR210C antibodies?

To reduce background in immunofluorescence:

• Fixation optimization:

  • Issue: Overfixation causing autofluorescence

  • Solution: Reduce fixation time; test different fixatives (PFA vs. methanol)

• Blocking enhancements:

  • Issue: Insufficient blocking

  • Solution: Extend blocking time to 1-2 hours; use higher concentration of blocking agents (5-10% serum); add 0.1-0.3% Triton X-100 to blocking buffer

• Antibody dilution adjustments:

  • Issue: Too concentrated primary antibody

  • Solution: Test serial dilutions (1:200, 1:500, 1:1000); incubate longer at lower concentrations

• Washing improvements:

  • Issue: Insufficient washing

  • Solution: Increase number and duration of washes; use gentle agitation; add 0.05-0.1% Tween-20 to wash buffer

• Autofluorescence reduction:

  • Issue: Yeast cell autofluorescence

  • Solution: Include quenching steps (0.1% sodium borohydride); use appropriate filters; consider spectral unmixing

• Secondary antibody considerations:

  • Issue: Non-specific secondary antibody binding

  • Solution: Pre-absorb secondary antibodies; use highly cross-adsorbed versions; reduce concentration

• Mounting medium selection:

  • Issue: Suboptimal mounting medium

  • Solution: Use anti-fade mounting media with DAPI; allow mounting medium to cure properly

• Microscope settings optimization:

  • Issue: Improper exposure or gain settings

  • Solution: Optimize settings using control samples; use identical settings for comparable samples

For particularly challenging samples, consider using tyramide signal amplification for specific signal enhancement while maintaining low background .

What should I do if I observe conflicting results between different antibodies targeting YGR210C?

When faced with conflicting results between different YGR210C antibodies:

• Epitope mapping:

  • Determine which regions of YGR210C each antibody targets

  • Consider whether post-translational modifications might affect epitope recognition

  • Assess whether protein conformation differences impact antibody binding

• Validation status assessment:

  • Review validation data for each antibody

  • Perform side-by-side validation tests on identical samples

  • Test antibodies against recombinant protein and knockout controls

• Application-specific comparisons:

  • Evaluate if discrepancies are technique-specific (e.g., one antibody works for WB but not IF)

  • Optimize protocols separately for each antibody

  • Consider that different epitopes may be accessible in different applications

• Orthogonal validation:

  • Use non-antibody methods to resolve contradictions (mass spectrometry, RNA analysis)

  • Generate tagged versions of YGR210C for independent detection

  • Consider CRISPR-based endogenous tagging for definitive localization

• Functional context consideration:

  • Assess whether conflicting results reflect biological variation (e.g., cell cycle-dependent changes)

  • Test whether experimental conditions affect epitope accessibility differently

  • Evaluate whether protein interactions might mask certain epitopes

When publishing, transparently report conflicting results and provide possible explanations based on the above analyses .

How can I adapt chromatin immunoprecipitation protocols for YGR210C to study its genome-wide binding pattern?

Adapting ChIP protocols for genome-wide YGR210C binding studies:

• Cross-linking optimization for yeast cells:

  • Use 1% formaldehyde for 15 minutes at room temperature

  • Consider dual cross-linking with DSG (2 mM, 45 minutes) followed by formaldehyde

  • Quench with 125 mM glycine for 5 minutes

• Chromatin preparation:

  • Lyse cells with glass beads in lysis buffer (50 mM HEPES pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, protease inhibitors)

  • Sonicate to generate 200-300 bp fragments (verify by gel electrophoresis)

  • Clear lysate by centrifugation at 14,000 × g for 10 minutes

• Immunoprecipitation refinements:

  • Pre-clear chromatin with Protein A/G beads for 1 hour

  • Use 3-5 μg of anti-YGR210C antibody per IP

  • Incubate overnight with rotation at 4°C

  • Add 50 μl of Protein A/G beads and incubate for 3 hours

• Washing and elution:

  • Perform stringent washes with increasing salt concentrations (150-500 mM NaCl)

  • Include LiCl wash buffer to reduce non-specific binding

  • Elute with 1% SDS, 0.1 M NaHCO₃ at 65°C

• DNA purification and library preparation:

  • Reverse cross-links overnight at 65°C

  • Treat with RNase A and Proteinase K

  • Purify DNA using phenol-chloroform extraction or commercial kits

  • Prepare libraries using methods optimized for low-input samples

• Bioinformatic analysis:

  • Map reads to the yeast genome using Bowtie2 or BWA

  • Call peaks using MACS2 with appropriate parameters for yeast

  • Use input and IgG controls for normalization

  • Perform motif discovery using MEME or HOMER

This protocol is derived from successful approaches used for other yeast transcription factors and chromatin-associated proteins .

What are the considerations for using YGR210C antibodies in super-resolution microscopy?

For super-resolution microscopy with YGR210C antibodies:

• Antibody selection criteria:

  • Use high-affinity antibodies with minimal background

  • Consider directly conjugated primary antibodies to reduce linkage error

  • For STORM/PALM, select antibodies compatible with photoswitchable dyes

• Sample preparation refinements:

  • Use thinner sections or optimized clearing methods

  • For STED, use <100 nm sections when possible

  • Optimize fixation to maintain structure while preserving epitope accessibility

• Labeling strategies:

  • For STORM: Use Alexa Fluor 647 or Cy5 dyes for optimal photoswitching

  • For STED: Select dyes with appropriate depletion characteristics (ATTO 647N, Abberior STAR dyes)

  • For dual-color imaging, select spectrally separated fluorophores

• Validation approaches:

  • Perform correlative imaging with conventional microscopy

  • Validate structures with orthogonal super-resolution techniques

  • Use positive controls with known structures for comparison

• Technical considerations:

  • Ensure mechanical stability during acquisition

  • Use appropriate buffers for specific techniques (oxygen scavenging for STORM)

  • Optimize labeling density (too dense: overlapping signals; too sparse: incomplete structures)

• Analysis approaches:

  • Apply drift correction and channel alignment

  • Consider cluster analysis for quantitative assessment

  • Use appropriate reconstruction algorithms

• Biological interpretation:

  • Relate nanoscale organization to function

  • Compare with electron microscopy data when available

  • Consider temporal dynamics with live-cell compatible approaches

This approach enables visualization of YGR210C localization and interactions at nanometer resolution, providing insights into its spatial organization that conventional microscopy cannot resolve .

How can I develop a quantitative immunoprecipitation-mass spectrometry (qIP-MS) workflow to identify YGR210C protein interactions?

Developing a qIP-MS workflow for YGR210C interactions:

• SILAC labeling setup:

  • Grow yeast in light (natural) or heavy (¹³C₆-arginine, ¹³C₆-lysine) media

  • Ensure complete incorporation through multiple passages

  • Use label-swap replicates to control for labeling artifacts

• Optimized immunoprecipitation:

  • Use formaldehyde cross-linking (0.05-0.1%) to capture transient interactions

  • Perform parallel IPs with YGR210C antibody and control IgG

  • Include stringent washes to reduce non-specific binding

  • Elute with on-bead digestion or gentle elution methods

• Sample preparation for MS:

  • Perform in-solution or in-gel digestion with high-quality trypsin

  • Fractionate samples using high-pH reversed-phase chromatography

  • Desalt peptides using C18 stage tips

• LC-MS/MS analysis:

  • Use nanoflow LC coupled to high-resolution mass spectrometer

  • Implement data-dependent acquisition for discovery

  • Consider parallel reaction monitoring for targeted validation

• Data analysis pipeline:

  • Process raw data with MaxQuant or Proteome Discoverer

  • Calculate SILAC ratios for protein quantification

  • Apply statistical filtering (FDR <1%, minimum fold change >2)

  • Use visualization tools (volcano plots, interaction networks)

• Validation strategies:

  • Confirm key interactions by co-IP and western blotting

  • Use proximity ligation assay for in situ validation

  • Perform reciprocal IPs with antibodies against identified partners

• Functional categorization:

  • Analyze interactions using Gene Ontology enrichment

  • Map to known protein complexes and pathways

  • Integrate with existing interaction databases

This workflow enables quantitative assessment of YGR210C protein interactions, distinguishing specific interactors from background contaminants with statistical confidence .

How can YGR210C antibodies be used to study post-translational modifications of the target protein?

Using antibodies to study YGR210C post-translational modifications (PTMs):

• PTM-specific antibody approaches:

  • Use commercially available PTM-specific antibodies (phospho, acetyl, ubiquitin, etc.)

  • Develop custom antibodies against predicted PTM sites on YGR210C

  • Validate PTM-specific antibodies using appropriate controls (phosphatase treatment, deacetylase treatment)

• Enrichment strategies for modified forms:

  • Perform sequential immunoprecipitation (first with YGR210C antibody, then with PTM-specific antibody)

  • Use PTM-specific enrichment (TiO₂ for phosphopeptides, anti-diGly for ubiquitination sites)

  • Apply specific elution conditions to separate modified from unmodified proteins

• Mass spectrometry-based PTM mapping:

  • Immunoprecipitate YGR210C and analyze by LC-MS/MS

  • Use neutral loss scanning for phosphorylation

  • Apply electron transfer dissociation for labile modifications

  • Implement targeted approaches for low-abundance modifications

• Stimulus-dependent modification analysis:

  • Compare PTM profiles under different cellular conditions

  • Create time-course experiments following stimulation

  • Map kinetics of modification and correlation with function

• Functional validation of PTM sites:

  • Generate site-specific mutants (phosphomimetic, non-phosphorylatable)

  • Assess functional consequences of mutation

  • Use inhibitors of specific modification pathways to validate findings

• Localization of modified forms:

  • Perform immunofluorescence with PTM-specific antibodies

  • Track localization changes of modified forms during cellular processes

  • Co-stain with organelle markers to identify compartment-specific modifications

This methodology enables comprehensive characterization of YGR210C modifications and their functional significance in various cellular contexts .

How might synthetic antibody technologies improve YGR210C research?

Synthetic antibody technologies offer several advantages for YGR210C research:

• Recombinant antibody development:

  • Phage display libraries can generate highly specific antibodies against difficult epitopes

  • Yeast display systems enable direct selection for high-affinity binders

  • Synthetic antibody libraries can be designed with optimized frameworks for stability

• Nanobody applications:

  • Single-domain antibodies (nanobodies) provide access to epitopes inaccessible to conventional antibodies

  • Their small size (15 kDa) enables better penetration in live-cell imaging

  • Superior performance in super-resolution microscopy due to reduced linkage error

• Intrabody development:

  • Express antibody fragments intracellularly to study protein function

  • Monitor protein dynamics in living cells

  • Potentially interfere with specific protein-protein interactions

• Bispecific antibody approaches:

  • Target YGR210C and interaction partners simultaneously

  • Enhance specificity through avidity effects

  • Enable proximity-based studies with bispecific antibodies linked to split reporters

• Antibody engineering improvements:

  • Site-specific conjugation for optimal orientation on surfaces

  • Tunable affinity variants for specific applications

  • Reduced background through framework optimization

These technologies could overcome limitations of traditional antibodies, enabling more precise studies of YGR210C localization, interactions, and dynamics .

How can I integrate YGR210C antibody-based studies with CRISPR-Cas9 technologies?

Integrating antibody-based approaches with CRISPR-Cas9 provides powerful research synergies:

• Validation strategies:

  • Generate YGR210C knockout lines as definitive negative controls for antibody validation

  • Create epitope-tagged endogenous YGR210C for antibody comparison

  • Develop knock-in mutations to study specific functions while maintaining endogenous expression levels

• Functional genomics approaches:

  • Combine CRISPR screens with antibody-based phenotypic readouts

  • Use antibodies to quantify pathway activation in CRISPR-modified cells

  • Apply antibody-based sorting to enrich for CRISPR-edited populations

• PTM studies:

  • Generate specific PTM site mutants using CRISPR

  • Compare antibody-based PTM detection between wild-type and mutant cells

  • Create cellular systems to study modification dynamics

• Proximity-based applications:

  • Fuse APEX2 or BioID to YGR210C using CRISPR knock-in

  • Compare antibody-based interactome with proximity labeling

  • Validate interactions using complementary approaches

• Live-cell imaging innovations:

  • CRISPR knock-in of split fluorescent proteins for complementation with antibody-recruited fragments

  • Generate cell lines expressing degron-tagged YGR210C for inducible depletion studies

  • Create reporter lines for correlative antibody-based imaging

This integration provides complementary strengths: antibodies for detection versatility and CRISPR for precise genetic manipulation of the endogenous locus .

What role might YGR210C antibodies play in understanding evolutionary conservation of protein function across species?

YGR210C antibodies can provide valuable insights into evolutionary conservation:

• Cross-species reactivity assessment:

  • Test antibody reactivity against homologs in related yeast species

  • Evaluate conservation of epitopes across evolutionary distance

  • Map functionally conserved domains based on antibody cross-reactivity

• Comparative localization studies:

  • Use cross-reactive antibodies to compare subcellular localization across species

  • Identify conserved and divergent localization patterns

  • Correlate localization differences with functional adaptations

• Interactome evolution analysis:

  • Compare immunoprecipitation-mass spectrometry results across species

  • Identify core conserved interactions versus species-specific partners

  • Map interaction interface evolution through epitope-specific antibodies

• Functional conservation mapping:

  • Use antibodies to track protein expression in complementation studies

  • Monitor whether human orthologs can replace yeast protein function

  • Analyze modification patterns across species using PTM-specific antibodies

• Structural conservation assessment:

  • Use conformation-specific antibodies to evaluate structural conservation

  • Map functional domains through differential epitope accessibility

  • Correlate structure with function across evolutionary distance